Inlyta 1mg Tablet: Effective Treatment for Advanced Renal Cancer

Uses:

• Advanced kidney cancer (renal cell carcinoma).

Therapeutic Effects:

• Belongs to the category of tyrosine kinase inhibitors, which interferes with the growth of blood vessels inside the cancer cells.
• Acts against a protein called receptor tyrosine kinases to interrupt cell signalling, ultimately stopping the growth and spread of cancer cells.

Dosage and Administration:

• The recommended starting oral dose is 5 mg twice daily.
• Take the tablet at the same time every day, with or without food.
• Do not chew, crush, or break the tablet. Swallow the whole tablet with water.
• Always take this medicine as prescribed by your doctor.

Safety Advice:

• Pregnancy: not recommended for pregnant women as it may cause fetal harm.
• Breastfeeding: unsafe to breastfeed during the treatment with Inlyta 1mg tablet.
• Lungs: consult your doctor if you have any lung diseases before starting the treatment.
• Liver: inform your doctor if you have any liver problems before taking Inlyta 1mg tablet.
• Alcohol: consuming alcohol may affect the effectiveness of Inlyta 1mg tablet.
• Driving: it is unsafe to drive vehicles or operate heavy machinery after taking Inylta 1mg tablets.

Interaction with Other Drugs:

• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.

Side Effects:

• Serious: extreme tiredness and swelling, pressure or pain in the chest, arms, back, neck or jaw, breathlessness, numbness and weakness on one side of the body, difficulty speaking or communicating verbally, headache, vision changes or dizziness, serious bleeding problems like black tarry stools, bloody cough or bloody sputum, severe stomach pain, high blood pressure.
• Common: kidney problems, dehydration, hyper-active thyroid gland, sore throat, loss of appetite, joint pain, lack of energy, weight loss, constipation, mouth sores, skin itching, redness of skin and hair loss.

Word of Advice:

• Inylta 1mg tablet can make you feel dizzy and weak. Avoid driving or operating heavy machines if you experience dizziness, confusion, or tiredness while on treatment with this drug.
• Grapefruit or grapefruit juice may also increase drug plasma concentrations and should be avoided.
• Some formulations of axitinib may contain lactose as an inactive ingredient. If you have lactose intolerance, inform your doctor before starting this therapy.

FAQs:

1. What are the most common side effects of Inylta 1mg tablet? The common side effects that are likely to occur while you are on the treatment with Inylta 1mg tablet are high blood pressure, diarrhea, nausea, vomiting, constipation, indigestion, soreness in the mouth, tongue, or throat, shortness of breath, cough, tiredness, weakness, dehydration, loss of appetite, joint pain, weight loss, headache, muscle pain, nose bleeding, tinnitus, itching, hair loss, dizziness, and inflammation of the gallbladder.

2. Is it safe to use Inylta 1mg tablet during pregnancy? Inylta 1mg tablet may cause harm to an unborn baby. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby.

3. Is it safe to undergo surgery during the treatment with Inylta 1mg tablet? Inylta 1mg tablet is associated with an increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and tell your physician before you undergo surgery or dental procedures.

4. What should you not take with Inylta 1mg tablet? It is not recommended to take grapefruit and grapefruit juice while on treatment with Inylta 1mg tablet. Tell your healthcare provider if you are taking any prescription medicines, over-the-counter drugs, vitamins, or herbal supplements.

5. What are all the dosage forms and strengths available for Inylta 1mg tablet? This drug is available in the form of film-coated tablets in doses 1mg, 3mg, 5mg, and 7mg. The usual recommended dose is 5mg twice a day.

Fact Box:

• Molecule name: Axitinib.
• Therapeutic class: Anticancer.
• Pharmacological class: Tyrosine kinase inhibitors.
• Indications: Advanced kidney cancer.

Tags: inlyta, tablet, 1mg, medication, drug, cancer-treatment